Stopped: Insufficient enrollment
This is a prospective randomized, double-blind study to compare the clinical efficacy of infantile hemangioma treatment using propranolol with corticosteroids as compared to therapy with corticosteroids and placebo. We hypothesize that a two-month treatment period with propranolol plus corticosteroids is more effective at reducing infantile hemangioma size and vascularity when compared to corticosteroids used without propranolol for the same time period.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Compare Changes in IH Size and Vascularity for the Two Treatment Groups
Timeframe: 1, 2, and 6 months after treatment initiation
Lesion Regression
Timeframe: 12 months